News
There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
The company said it was notified Wednesday that the Health and Human Services Department had withdrawn funds awarded.
There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...
Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...
6d
MedPage Today on MSNTrump Admin Cancels $766M Moderna Contract to Fight Pandemic Flu, Including H5N1The Trump administration has canceled $766 million awarded to drugmaker Moderna to develop a vaccine against potential ...
The funding boost Moderna Inc. had expected via a roughly $590 million Biomedical Advanced Research and Development Authority award now looks to be off the table. The company disclosed May 28 that the ...
With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.
The Global Sepsis Diagnostics Market valued at ~$510 million (2021) is set to witness a healthy growth rate of 9% in the next 5 years. Development of rapid diagnostic tests/point-of-care techniques, ...
Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.
Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results